5. References
- Clinical Pharmacology [database online]. Tampa, FL: Gold Standard, Inc.; 2022. Available at: http://clinicalpharmacology-ip.com.ezproxy.lib.utexas.edu/. Accessed September 21, 2022.
- IMB Micromedex® DRUGDEX® (electronic version). Truven Health Analytics, Greenwood Village, Colorado, USA. Available at: http://www.micromedexsolutions.com.libproxy.uthscsa.edu. Accessed September 21, 2022.
- Amphetamine mixed salts tablets (Adderall®) package insert. Teva Pharmaceuticals USA, Inc., February 2022.
- Amphetamine mixed salts extended-release capsules (Adderall XR®) package insert. Takeda Pharmaceuticals America, Inc., March 2022.
- Amphetamine mixed salts extended-release capsules (Mydayis®) package insert. Takeda Pharmaceuticals America, Inc., March 2022.
- Amphetamine extended-release orally disintegrating tablets (Adzenys XR-ODT®) package insert. Neos Therapeutics, Inc., March 2022.
- Amphetamine extended-release oral suspension (Dyanavel® XR) package insert. Nextwave Pharmaceuticals, Inc., May 2022.
- Dexmethylphenidate tablets (Focalin®) package insert. Novartis Pharmaceuticals Corp., June 2022.
- Dexmethylphenidate extended-release capsules (Focalin® XR) package insert. Novartis Pharmaceuticals Corp., June 2021.
- Dextroamphetamine transdermal system (Xelstrym®) package insert. Noven Therapeutics, LLC., March 2022.
- Lisdexamfetamine capsule and chewable tablets (Vyvanse®) package insert. Takeda Pharmaceuticals America, Inc., March 2022.
- Methylphenidate extended release capsules (Adhansia XR®) package insert. Adlon Therapeutics LP, July 2022.
- Methylphenidate extended-release capsules (Aptensio XR®) package insert. Rhodes Pharmaceuticals, June 2021.
- Methylphenidate extended-release tablets (Concerta®) package insert. Janssen Pharmaceuticals, Inc., April 2022.
- Methylphenidate extended-release capsules (Jornay PM®) package insert. Ironshore Pharmaceuticals, Inc., March 2022.
- Methylphenidate extended-release capsules (Metadate CD®) package insert. Lannett Company, Inc., April 2022.
- Methylphenidate extended-release tablets package insert. KVK-Tech, Inc., April 2021.
- Methylphenidate oral solution (Methylin®) package insert. Shionogi Pharma, Inc., July 2021.
- Methylphenidate chewable tablets package insert. Camber Pharmaceuticals, Inc., August 2021.
- Methylphenidate extended-release tablets (Relexxii®) package insert. Vertical Pharmaceuticals, LLC. November 2021.
- Methylphenidate tablets (Ritalin®) package insert. Novartis Pharmaceuticals Corp., June 2021.
- Methylphenidate extended-release capsules (Ritalin LA®) package insert. Novartis Pharmaceuticals Corp., June 2021.
- Methylphenidate tablets, extended-release tablets package insert. Ascend Laboratories, LLC., December 2019.
- Methylphenidate extended-release chewable tablets (QuilliChew® XR) package insert. NextWave Pharmaceuticals, Inc. June 2021.
- Methylphenidate extended-release oral suspension (Quillivant® XR) package insert. NextWave Pharmaceuticals, Inc. June 2021.
- Serdexmethylphenidate and dexmethylphenidate capsules (Azstarys®) package insert. Corium, Inc., May 2022.
- Atomoxetine (Strattera®) package insert. Eli Lilly and Company, January 2022.
- Viloxazine extended-release capsules (Qelbree®) package insert. Supernus Pharmaceuticals, Inc., May 2022.
- Guanfacine extended-release tablets (Intuniv®) package insert. Takeda Pharmaceuticals America Inc., January 2021.
- Texas Health and Human Services. Psychotropic medication utilization parameters for children and youth in Texas Public Behavioral Health (6th version). June 2019. Accessed September 22, 2022. Available at: https://www.hhs.texas.gov/sites/default/files/documents/doing-business-with-hhs/provider-portal/facilities-regulation/psychiatric/psychotropic-medication-utilization-parameters.pdf.
- Amphetamine sulfate tablets (Evekeo®) package insert. Arbor Pharmaceuticals. January 2022.
- Amphetamine sulfate oral disintegrating tablets (Evekeo ODT®) package insert. Arbor Pharmaceuticals. March 2022.
- Dextroamphetamine tablets package insert. Aurolife Pharma, LLC., January 2022.
- Dextroamphetamine extended-release capsules (Dexedrine® Spansule) package insert. Amneal Pharmaceuticals, LLC., January 2022.
- Dextroamphetamine oral solution (ProCentra®) package insert. Independence Pharmaceuticals, June 2022.
- Dextroamphetamine tablets (Zenzedi®) package insert. Arbor Pharmaceuticals, LLC, January 2022.
- Methamphetamine tablets (Desoxyn®) package insert. Key Therapeutics, September 2022.
- Methylphenidate extended-release orally disintegrating tablets (Cotempla XR-ODT®) package insert. Neos Therapeutics, Inc., July 2021.
- Methylphenidate transdermal system (Daytrana®) package insert. Noven Pharmaceuticals, June 2021.
- Clonidine extended-release tablets (Kapvay®) package insert. Concordia Pharmaceuticals, Inc., August 2021.
- Diagnostic and Statistical Manual of Mental Disorders: DSM-5-TR. 5th ed., American Psychiatric Association, 2022.
- Wolraich ML, Hagan JF, Allan C, et. al. Subcommittee on Children and Adolescents with Attention-Deficit/Hyperactive Disorder; clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Pediatrics. October 2019; 144 (4): e20192528. 10.1542/peds.2019-2528.